Initial information regarding unsolicited case from United States was received from a Consumer (patient Mother) 
and transmitted to Sanofi on 28-Jan-2016
This case involves a 6 year-old male patient for whom product taste abnormal reported after starting fexofenadine 
hydrochloride (Allegra Children's Orally Disintegrating Tablet OTC). 
Relevant medical history: unknown
Concomitant medications: unknown
Print Time: 15-JUL-2016 02:45 PM If a field is blank, there is no data for that field Page 248 of 250
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
On an unknown date (3 days ago) the patient was started fexofenadine hydrochloride 30 mg tablet via oral route 
daily (Lot number: 5DJ4A, expiration date: 30-NOV-2017) for allergies.
On an unknown date, (latency period: unknown) after the initiation of fexofenadine hydrochloride, the patient 
experienced horrible taste/ complained of a bad taste. The patient Mother took one of the tablets herself and stated 
that it had a bad taste.
Action taken: Not Applicable
Therapy with fexofenadine hydrochloride was stopped on an unknown date.
Event outcome: Not Applicable
Sanofi causal assessment: Unclassified
No further relevant information was reported.